Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05254457 · ClinicalTrials.gov registry record · Phase 3
Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis
A Phase 3 study of Plantar Fibromatosis, sponsored by Endo Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 145
- Enrollment target
- 20
- Study locations
NCT05254457 is a Phase 3 study of Plantar Fibromatosis that has completed, run by Endo Pharmaceuticals. The registered enrollment target is 145 participants. The trial reports 20 study locations across 9 states.
The verdict
NCT05254457, a Phase 3 study of Plantar Fibromatosis, has completed, sponsored by Endo Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 145 participants
- Enrollment target
- 20
- Study locations
Study Summary
Assess the long-term safety and efficacy of EN3835 in participants who have participated in a parent placebo-controlled study of EN3835 (EN3835-222, NCT05152173) and assess the efficacy and safety of EN3835 in the treatment and retreatment of plantar fibromatosis.
Conditions Studied
Interventions
- BIOLOGICAL EN3835
Study Locations (20)
California
- Endo Clinical Trial Site #12 - Bakersfield
- Endo Clinical Trial Site #3 - Fresno
- Endo Clinical Trial Site #23 - La Mesa
- Endo Clinical Trial Site #13 - Tarzana
- Endo Clinical Trial Site #15 - Vista
- Endo Clinical Trial Site #18 - Whittier
Florida
- Endo Clinical Trial Site #24 - Miami
- Endo Clinical Trial Site #8 - Pinellas Park
- Endo Clinical Trial Site #21 - Sweetwater
Illinois
- Endo Clinical Trial Site #19 - Decatur
- Endo Clinical Trial Site #2 - O'Fallon
- Endo Clinical Trial Site #14 - Springfield
Texas
- Endo Clinical Trial Site #4 - Bedford
- Endo Clinical Trial Site #17 - Dallas
- Endo Clinical Trial Site #26 - Dallas
Georgia
- Endo Clinical Trial Site #22 - Lawrenceville
Idaho
- Endo Clinical Trial Site #25 - Meridian
Maryland
- Endo Clinical Trial Site #6 - Pasadena
Missouri
- Endo Clinical Trial Site #16 - Jefferson City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2022-02-14 |
| Est. Completion | 2024-03-21 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05254457
The ClinicalTrials.gov registry entry for NCT05254457 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endo Pharmaceuticals, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Plantar Fibromatosis appearing as the primary indexed condition, and to 1 intervention - of which EN3835 is the first listed.
NCT05254457 reports 20 study locations spanning 9 distinct geographic areas - top geographies include California, Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT05254457 about?
NCT05254457 is a clinical study titled "Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis". Assess the long-term safety and efficacy of EN3835 in participants who have participated in a parent placebo-controlled study of EN3835 (EN3835-222, NCT05152173) and assess the efficacy and safety of EN3835 in the treatment and retreatment of plantar fibromatosis.
What is the current status of trial NCT05254457?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 145 participants. The study started on 2022-02-14. Estimated completion is 2024-03-21.
What conditions does trial NCT05254457 study?
This clinical trial studies the following conditions: Plantar Fibromatosis.
What interventions are being tested in trial NCT05254457?
The interventions under investigation include: EN3835 (BIOLOGICAL).
Who is sponsoring clinical trial NCT05254457?
This trial is sponsored by Endo Pharmaceuticals, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05254457 being conducted?
This trial has 20 study locations across California, Florida, Georgia, Idaho, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Plantar Fibromatosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.